Amic Forging Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 26, 2025, 6:43 pm

Competitors of Amic Forging Ltd

All Competitor Stocks of Amic Forging Ltd

Quarterly Result

Last Updated: July 16, 2025, 2:55 pm

Below is a detailed analysis of the quarterly data for Amic Forging Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Sep 2024) to 58.00 Cr., marking a decrease of 6.00 Cr..
• For Expenses, as of Mar 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 52.00 Cr. (Sep 2024) to 42.00 Cr., marking a decrease of 10.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Sep 2024) to 16.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Mar 2025, the value is 28.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Sep 2024) to 28.00%, marking an increase of 9.00%.
• For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 15.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Sep 2024) to 17.00 Cr., marking a decrease of 12.00 Cr..
• For Tax %, as of Mar 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Sep 2024) to 23.00%, marking an increase of 2.00%.
• For Net Profit, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Sep 2024) to 13.00 Cr., marking a decrease of 10.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 11.37. The value appears to be declining and may need further review. It has decreased from 21.66 (Sep 2024) to 11.37, marking a decrease of 10.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:58 am

Growth

Last Updated: September 5, 2025, 2:16 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Amic Forging Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 33.90. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 33.90, marking an increase of 17.84.
• For Diluted EPS (Rs.), as of Mar 25, the value is 33.90. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 33.90, marking an increase of 17.84.
• For Cash EPS (Rs.), as of Mar 25, the value is 36.64. This value is within the healthy range. It has increased from 13.89 (Mar 24) to 36.64, marking an increase of 22.75.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.60. It has increased from 61.59 (Mar 24) to 118.60, marking an increase of 57.01.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.60. It has increased from 61.59 (Mar 24) to 118.60, marking an increase of 57.01.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 115.67. It has decreased from 120.27 (Mar 24) to 115.67, marking a decrease of 4.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 46.44. This value is within the healthy range. It has increased from 18.93 (Mar 24) to 46.44, marking an increase of 27.51.
• For PBIT / Share (Rs.), as of Mar 25, the value is 43.70. This value is within the healthy range. It has increased from 18.25 (Mar 24) to 43.70, marking an increase of 25.45.
• For PBT / Share (Rs.), as of Mar 25, the value is 43.31. This value is within the healthy range. It has increased from 17.75 (Mar 24) to 43.31, marking an increase of 25.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 33.90. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 33.90, marking an increase of 20.70.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.90. This value is within the healthy range. It has increased from 13.19 (Mar 24) to 33.90, marking an increase of 20.71.
• For PBDIT Margin (%), as of Mar 25, the value is 40.14. This value is within the healthy range. It has increased from 15.73 (Mar 24) to 40.14, marking an increase of 24.41.
• For PBIT Margin (%), as of Mar 25, the value is 37.78. This value exceeds the healthy maximum of 20. It has increased from 15.17 (Mar 24) to 37.78, marking an increase of 22.61.
• For PBT Margin (%), as of Mar 25, the value is 37.44. This value is within the healthy range. It has increased from 14.75 (Mar 24) to 37.44, marking an increase of 22.69.
• For Net Profit Margin (%), as of Mar 25, the value is 29.30. This value exceeds the healthy maximum of 10. It has increased from 10.97 (Mar 24) to 29.30, marking an increase of 18.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 29.30. This value exceeds the healthy maximum of 20. It has increased from 10.96 (Mar 24) to 29.30, marking an increase of 18.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 28.58. This value is within the healthy range. It has increased from 21.41 (Mar 24) to 28.58, marking an increase of 7.17.
• For Return on Capital Employeed (%), as of Mar 25, the value is 36.63. This value is within the healthy range. It has increased from 28.24 (Mar 24) to 36.63, marking an increase of 8.39.
• For Return On Assets (%), as of Mar 25, the value is 23.28. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 23.28, marking an increase of 8.27.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has decreased from 1.65 (Mar 24) to 0.99, marking a decrease of 0.66.
• For Current Ratio (X), as of Mar 25, the value is 2.63. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 2.63, marking an increase of 0.66.
• For Quick Ratio (X), as of Mar 25, the value is 2.05. This value exceeds the healthy maximum of 2. It has increased from 1.96 (Mar 24) to 2.05, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.79. This value exceeds the healthy maximum of 8. It has decreased from 28.23 (Mar 24) to 14.79, marking a decrease of 13.44.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 118.59. This value is within the healthy range. It has increased from 37.86 (Mar 24) to 118.59, marking an increase of 80.73.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 87.58. This value is within the healthy range. It has increased from 27.41 (Mar 24) to 87.58, marking an increase of 60.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,113.64. It has increased from 685.59 (Mar 24) to 1,113.64, marking an increase of 428.05.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.18. This value exceeds the healthy maximum of 3. It has increased from 5.43 (Mar 24) to 9.18, marking an increase of 3.75.
• For EV / EBITDA (X), as of Mar 25, the value is 22.86. This value exceeds the healthy maximum of 15. It has decreased from 34.53 (Mar 24) to 22.86, marking a decrease of 11.67.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.34. This value exceeds the healthy maximum of 3. It has increased from 5.50 (Mar 24) to 9.34, marking an increase of 3.84.
• For Price / BV (X), as of Mar 25, the value is 9.11. This value exceeds the healthy maximum of 3. It has decreased from 10.74 (Mar 24) to 9.11, marking a decrease of 1.63.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.34. This value exceeds the healthy maximum of 3. It has increased from 5.50 (Mar 24) to 9.34, marking an increase of 3.84.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness